Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Jodie L. Babitt, Michele F. Eisenga, Volker H. Haase, et al.
Kidney International (2021) Vol. 99, Iss. 6, pp. 1280-1295
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients
A. Velleca, M. Shullo, K. Dhital, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 42, Iss. 5, pp. e1-e141
Open Access | Times Cited: 270
Hepcidin and Iron in Health and Disease
Elizabeta Nemeth, Tomas Ganz
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 261-277
Open Access | Times Cited: 213
Iron deficiency and cardiovascular disease
Gianluigi Savarese, Stephan von Haehling, Javed Butler, et al.
European Heart Journal (2022) Vol. 44, Iss. 1, pp. 14-27
Open Access | Times Cited: 120
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Elaine Ku, Lucia Del Vecchio, Kai‐Uwe Eckardt, et al.
Kidney International (2023) Vol. 104, Iss. 4, pp. 655-680
Open Access | Times Cited: 72
The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anemia of inflammation
Oriana Marques, Günter Weiß, Martina U. Muckenthaler
Blood (2022) Vol. 140, Iss. 19, pp. 2011-2023
Closed Access | Times Cited: 69
Dapagliflozin and Anemia in Patients with Chronic Kidney Disease
Akihiko Koshino, Meir Schechter, Glenn M. Chertow, et al.
NEJM Evidence (2023) Vol. 2, Iss. 6
Open Access | Times Cited: 33
Iron-Deficiency Anemia in CKD: A Narrative Review for the Kidney Care Team
Debra Hain, Donna Bednarski, Molly Cahill, et al.
Kidney Medicine (2023) Vol. 5, Iss. 8, pp. 100677-100677
Open Access | Times Cited: 23
Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management
Krzysztof Badura, Jędrzej Jerzy Janc, Joanna Wąsik, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1191-1191
Open Access | Times Cited: 15
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association
Sokratis Stoumpos, Kirsty Crowe, Pantelis Sarafidis, et al.
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 10, pp. 1710-1730
Open Access | Times Cited: 11
The impact of different exercise modalities on chronic kidney disease: an umbrella review of meta-analyses
H. L. Correa, Thiago dos Santos Rosa, Rafael Lavarini dos Santos, et al.
Frontiers in Physiology (2025) Vol. 15
Open Access | Times Cited: 1
Iron Deficiency and Nephrotoxic Heavy Metals: A Dangerous Interplay?
Pien Rawee, Daan Kremer, Ilja M. Nolte, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5315-5315
Open Access | Times Cited: 19
Clinical Significance of Trace Element Zinc in Patients with Chronic Kidney Disease
Hirotaka Fukasawa, Ryuichi Furuya, Mai Kaneko, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1667-1667
Open Access | Times Cited: 13
Critical re‐evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1298-1312
Open Access | Times Cited: 5
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?
Rehma Siddiqui, Yoshitsugu Obi, Neville R. Dossabhoy, et al.
Current Hypertension Reports (2024) Vol. 26, Iss. 12, pp. 463-474
Open Access | Times Cited: 5
Recent and Emerging Therapies for Iron Deficiency in Anemia of CKD: A Review
Jonathan W. Bazeley, Jay B. Wish
American Journal of Kidney Diseases (2021) Vol. 79, Iss. 6, pp. 868-876
Open Access | Times Cited: 32
Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study
Hiroshi Kataoka, Toshio Mochizuki, Mamiko Ohara, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: A network meta-analysis
Junlan Yang, Jie Xing, Xiaodong Zhu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial
Akihiko Koshino, Brendon L. Neuen, Niels Jongs, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Mechanosensitive Cation Channel Piezo1 Is Involved in Renal Fibrosis Induction
Marta Drobnik, Jakub Smólski, Łukasz Grądalski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1718-1718
Open Access | Times Cited: 4
First‐in‐Human Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of DISC‐0974, an Anti‐Hemojuvelin Antibody, in Healthy Participants
Natasha Novikov, Akshay Buch, Hua Yang, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 8, pp. 953-962
Closed Access | Times Cited: 4
Role of Nutrients in Pediatric Non-Dialysis Chronic Kidney Disease: From Pathogenesis to Correct Supplementation
Flavia Padoan, Matteo Guarnaroli, Milena Brugnara, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 911-911
Open Access | Times Cited: 4
Iron biology
Lucia Del Vecchio, Domenico Girelli, Francesca Vinchi, et al.
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 9, pp. 1404-1415
Closed Access | Times Cited: 4
Non-Classical Effects of FGF23: Molecular and Clinical Features
Luis Martínez-Heredia, Juan Manuel Canelo Moreno, Beatriz García-Fontana, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4875-4875
Open Access | Times Cited: 4
Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney disease
Volker H. Haase, Tetsuhiro Tanaka, Mark J. Koury
Hematology (2024) Vol. 2024, Iss. 1, pp. 409-418
Closed Access | Times Cited: 4
Prevalence and Treatment Patterns of Anaemia in Individuals With Chronic Kidney Disease Across Asia: A Systematic Review and Meta‐Analysis
Dana Kim, Joshua D. Lee, Tadashi Toyama, et al.
Nephrology (2025) Vol. 30, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top